Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07506889Not Yet Recruiting

Simplified Exercise-based Risk Assessment in Lung Cancer

Role: collaborator

NCT07381959Recruiting

Biomarkers of Brain Injury in Children With Brain Tumors

Role: collaborator

NCT06795074Phase 4Recruiting

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

Role: collaborator

NCT05821894Recruiting

Carotid Plaque Imaging Project (CPIP)

Role: collaborator

NCT04239612Not ApplicableCompleted

Fitforlife- Exercise in Care of Psychosis

Role: collaborator

All 5 trials loaded